glucagon has been researched along with Cardiac Failure in 156 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 139 (89.10) | 18.7374 |
| 1990's | 3 (1.92) | 18.2507 |
| 2000's | 3 (1.92) | 29.6817 |
| 2010's | 7 (4.49) | 24.3611 |
| 2020's | 4 (2.56) | 2.80 |
| Authors | Studies |
|---|---|
| Martens, P; Mathieu, C; Vanassche, T | 1 |
| Abbasnezhad, A; Abd El-Ghafar, OA; Abhilash, L; Abouzid, KAM; Achberger, AM; Ackerman, S; Akhatayeva, Z; Akin, D; Al-Kaysi, RO; Alakhdar, AA; Alame, M; Aleksic Sabo, V; Alinezhadbalalami, N; Allen, JD; Alonso, JM; Alqatani, S; Alsayed, B; Álvarez Larraondo, M; Alvarez, M; Amini, SB; An, Z; Anasir, MI; Anderson, GH; Andremont, A; Andrés, S; Angel, S; Anigboro, AA; Anini, Y; Antonides, CFJ; Arafa, K; Arafa, RK; Aryal, UK; Asbaghi, O; Assefa, MK; Atyah, M; Avwioroko, OJ; Ayora-Talavera, G; Azpilikueta, A; Azyazov, VN; Ba, YF; Bachmann, KF; Badoual, J; Bae, SJ; Baek, SH; Bahrami, B; Bai, J; Baid-Agrawal, S; Bailey, MR; Baillie, JK; Balani, N; Balcar, VJ; Banica, T; Banks, L; Barb, J; Bardeen, CJ; Barrett, HE; Bartnikowski, N; Bashir, R; Battaglia, M; Bautista-Hernández, V; Becker, B; Beekman, FJ; Benidir, M; Benjelloun, M; Bentley, RF; Bergé, J; Berger, D; Bernsen, MR; Berraondo, P; Bhattacharya, R; Bhayani, SB; Bi, W; Bi, X; Bi, YL; Bi, Z; Bian, K; Biesecker, LG; Billadeau, DD; Blaszczyk, R; Blum, JL; Boachie, R; Boelte, K; Bogers, AJJC; Boileau, I; Bonduelle, C; Bonny, O; Bonsu, JM; Boos, LA; Borges-Argáez, R; Bouchard, PA; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Boyle, AJ; Branigan, D; Briones, S; Broniowska, KA; Brossas, JY; Brown, WA; Brzezinska, J; Buitron, G; Burnier, M; Bursulaya, B; Burton, PR; Bush, AA; Busuttil, RW; Cabello-Aguilar, S; Cáceres-Farfán, M; Cacheux, V; Caffrey, PJ; Cai, B; Cai, Q; Cai, S; Cai, Y; Calders, P; Cammarota, G; Campbell, DA; Cancelli, C; Cao, Q; Cao, WH; Cao, X; Capet, M; Capoluongo, E; Carey, ME; Carnero, M; Carrasco, LI; Carreno, J; Carrillo-Reyes, J; Casini, I; Cassar, M; Catalan, G; Cattamanchi, A; Cazares-Granillo, M; Celie, B; Cen, YK; Cena, H; Cerbo, RM; Ceron, E; Cetina-Montejo, L; Chaâbane-Banaoues, R; Chabanet, C; Chace-Donahue, F; Chalfun-Júnior, A; Chan-Balan, R; Chang, CS; Chen, CS; Chen, D; Chen, J; Chen, L; Chen, PN; Chen, Q; Chen, S; Chen, W; Chen, WP; Chen, X; Chen, Z; Cheng, H; Cheng, J; Cheng, Q; Cheng, T; Chi, T; Chianelli, D; Chieppa, M; Child, CJ; Cho, JH; Cho, JY; Chogtu, B; Choi, GH; Choi, J; Choi, M; Choi, NG; Cholu, CO; Chow, ES; Chowdhury, AH; Chu, PC; Chu, Q; Chu, S; Chua, H; Chung, T; Chunyan, L; Church, JS; Civardi, E; Cobiella, J; Colinge, J; Collado, CJ; Collins, TJ; Cong, LM; Conkrite, KL; Cope, SJ; Corbett, JA; Cornet, M; Cornillot, E; Corvaisier, S; Costes-Martineau, V; Courtioux, B; Coussens, M; Covino, M; Criado, A; Cui, J; Cui, Y; Cunitz, BW; Curry, AE; Cussó, L; D'Urzo, AD; D'Urzo, KA; Dabbous, S; Dahlgren, RA; Dai, H; Dai, T; Dai, W; Dalinghaus, M; Dang, S; Davalos, RV; Davidson, H; de Andrea, CE; De Angelis, M; de Blois, E; de Carvalho, PA; De Clercq, E; De Giuseppe, R; de Jong, M; De Langhe, S; De Oliveira, L; de Souza Pinto Lemgruber, R; de Souza, LB; de Swart, J; De Wandele, I; de Woestijne, PCV; Delaney, S; Delorme, M; Delvenne, P; Deng, L; Deng, Z; Denkinger, CM; der Meulen, MHV; Deraeve, C; Desco, M; DeSilva, S; Destere, A; Dhali, A; Di Ciano, P; Dias-Santagata, D; Diskin, SJ; Djè, MK; Doddipatla, S; Doerr, AJ; Dokla, EME; Domiciano, D; Domingo, N; Dong, C; Dong, J; Dong, Q; Dong, S; Dong, X; Dong, Z; Douair, I; Douglas, TA; Doyle, SM; Drain, PK; Du, K; Du, L; Du, Q; Du, S; Duan, C; Duan, H; Duan, J; Duan, S; Duan, W; Dueluzeau, R; Dukic, L; Dunmire, BL; Duvauchelle, T; Dymek, B; Dzwonek, K; Earnest, A; Eckardt, KU; El Ghadraoui, L; El Massoudi, S; Elloumi, F; Elnour, IE; Embarak, S; Ende, M; England, K; Enikeev, D; Enyedy, I; Epple, R; Erickson, GE; Eriksson, J; Erndt-Marino, J; Errachidi, F; Etxeberria, I; Evan, AP; Fairlamb, AH; Falahi, E; Fan, CC; Fan, H; Fan, M; Fan, MZ; Fan, S; Fan, Y; Fang, CS; Fang, J; Fang, X; Fang, Z; Farmany, A; Farooqi, A; Farouk, HO; Fazelipour, S; Feng, D; Feng, J; Feng, JX; Feng, YL; Ferraz, SL; Ferreira, CR; Figenshau, RS; Finn, AV; Fiseha, T; Fleischer, AS; Fogleman, AD; Fontaine, O; Ford, CR; Fouladvand, F; Four, M; Fousteri, G; Francis, JR; Fraser, JF; Frazier, RP; Fu, H; Fu, P; Fu, YJ; Fujishima, A; Fuster, V; Gabilan, JC; Gagliani, N; Gai, QY; Galán-Arriola, C; Gale, P; Galimova, GR; Galkin, A; Gallo, A; Gallo, AA; Gang, DD; Ganschow, S; Gao, C; Gao, F; Gao, GP; Gao, H; Gao, K; Gao, M; Gao, MY; Gao, P; Gao, R; Gao, S; Gao, WJ; Gao, Y; Garbacz, P; García Ruiz, L; Garcia, EM; Garofoli, F; Gasbarrini, A; Gattinoni, L; Gaudig, M; Gbureck, U; Ge, X; Genko, N; Gentile, GL; George, MW; Gerety, GF; Gestwicki, JE; Geusens, PP; Ghassemi, M; Giardina, JD; Giebultowicz, JM; Gifford, CA; Gijsen, FJH; Gilfillan, R; Gilson, E; Gingl, K; Giuliano, C; Glybochko, P; Goessler, W; Gofflot, S; Golab, J; Goldstein, A; Golebiowski, A; Gómez, L; Gómez-Carballo, J; Gonçalves, PEO; Gonzales, R; Gonzalez-Cotto, M; González-Fernández, D; Gonzalez-Lopez de Turiso, F; Goodman, JM; Govinda Raju, S; Grimm, J; Gross, AJ; Gruenheid, S; Gu, C; Gu, FF; Gu, S; Gu, Z; Guest, RL; Gui, C; Gui, J; Guillem, A; Guo, G; Guo, L; Guo, Q; Guo, S; Guo, SW; Guo, W; Guo, Y; Guo, YG; Guo, Z; Guretzky, JA; Haenggi, M; Hahn, MS; Hakkola, J; Halim, AA; Hampel, D; Han, B; Han, BH; Han, D; Han, G; Han, J; Han, LZ; Han, R; Han, S; Han, X; Han, Z; Handley, MA; Hanke, I; Hannongbua, S; Hao, P; Happ, JT; Hara, M; Haraux, F; Hare, JL; Harper, JD; Hartley, AM; Harvey, E; Hashimoto, K; Hassan, HM; Hautajärvi, H; Hayton, TW; He, C; He, H; He, HJ; He, WP; He, Y; He, Z; Hedrick, V; Heffernan, JK; Hegrová, J; Heidarimoghadam, R; Helms, K; Hengphasatporn, K; Henry, D; Herrmann, TRW; Hesson, T; Himmelbauer, MK; Hindle, A; Hoffmann, R; Hogg, N; Hong, KB; Hong, SK; Honjol, Y; Hood, C; Hsi, RS; Hsu, JL; Hu, B; Hu, BC; Hu, D; Hu, H; Hu, J; Hu, K; Hu, M; Hu, MK; Hu, T; Hu, W; Hu, Y; Hu, Z; Hua, S; Huang, H; Huang, J; Huang, L; Huang, M; Huang, P; Huang, X; Huang, Y; Huang, Z; Hukkanen, J; Hung, MC; Huo, X; Hyötyläinen, T; Ianiro, G; Ibanez, B; Imran, M; Ireland, S; Irwin, MS; Ishiguro, H; Jackowski, K; Jackson, C; Jacob, SI; Jahromy, MH; Jakob, SM; Jang, J; Javvaji, PK; Jefferson, KK; Jena, P; Ji, H; Jiang, F; Jiang, GH; Jiang, H; Jiang, J; Jiang, X; Jiang, Z; Jiao, J; Jiménez, A; Jin, X; Jincai, W; Jintao, X; Jo, K; Jofra, T; Johari, Y; Johnson, ACM; Jones, JH; Josephine Fauci, A; Juhl, AK; Jun, S; Kaiser, RI; Kajioka, J; Kajiyama, H; Kalliyil, A; Kalthur, SG; Kamalanathan, M; Kamaldinov, T; Kanaani, L; Kang, D; Kang, J; Kang, S; Känsäkoski, P; Kaplan, DL; Karwan, M; Kasibhatla, S; Kaur, A; Kawazoe, Y; Ke, C; Keyser, J; Khalique, A; Khan, IT; Kharshoum, RM; Kher, R; Kherani, J; Ki, KK; Kikkawa, F; Kikkawa, R; Kim, BT; Kim, EH; Kim, GA; Kim, GD; Kim, HB; Kim, HG; Kim, JS; Kim, MJ; Kim, SI; Kim, SJ; Kim, Y; King, K; Kinyamu-Akunda, J; Kirkkala, T; Kjaer-Sorensen, K; Kleppinger, EL; Kloner, RA; Klopfenstein, TJ; Knappe, D; Knezevic, P; Kobos, LM; Kohli, M; Kolano, L; Kolodgie, FD; Kolte, AP; Koneru, B; Kong, D; Kong, F; Kong, X; Konggidinata, MI; Köpke, M; Koski, KG; Kotsis, F; Köttgen, A; Kouakou-Kouamé, CA; Kraemer, US; Krane, V; Krehbiel, CR; Krenning, BJ; Kretzschmar, D; Ku, KB; Kubota, Y; Kulich, P; Kumar, NG; Kupiec-Weglinski, JW; Lalani, SS; Lan, X; Landfeldt, E; Langenberg, E; Lapauw, B; Larkin, J; Lassoued, MA; Laukhtina, E; Laura Martinez, J; Laveillé, A; Lavela, P; Law, AD; Lazraq, A; Le Foll, B; Lee, BK; Lee, C; Lee, CS; Lee, EJ; Lee, EY; Lee, G; Lee, HY; Lee, JH; Lee, JJ; Lee, JO; Lee, JS; Lee, R; Lei, H; Lei, P; Lellouche, F; Lennerz, JK; Leong, W; Leslie, I; Lessem, E; Levin, M; Levinger, I; Li, C; Li, CW; Li, CX; Li, CY; Li, D; Li, H; Li, HM; Li, J; Li, L; Li, LM; Li, N; Li, S; Li, W; Li, X; Li, XX; Li, Y; Li, Z; Li, ZL; Li, ZX; Lian, Q; Liang, C; Liang, GH; Liang, H; Liang, J; Liang, X; Liao, CX; Liao, R; Ličbinský, R; Lim, YS; Lima, HK; Lin, JG; Lin, L; Lin, S; Lin, WP; Lin, Z; Liso, M; Liu, BX; Liu, C; Liu, H; Liu, J; Liu, M; Liu, Q; Liu, S; Liu, SF; Liu, SL; Liu, T; Liu, W; Liu, X; Liu, XB; Liu, Y; Liu, YY; Liu, Z; Liu, ZQ; Lobo, M; Loitzenbauer, M; López, F; Lopez, G; López, GJ; Lou, Z; Lu, IC; Lu, J; Lu, M; Lu, W; Lu, X; Lu, Y; Luhovyy, BL; Luna-Abanto, J; Luo, J; Luo, K; Luo, L; Luo, M; Luo, W; Luo, X; Luo, XM; Lv, Y; Lv, YQ; Lyu, HD; Lyu, J; Ma, C; Ma, G; Ma, L; Ma, Q; Ma, X; Ma, Y; Macha, SJ; MacLean, E; Mahalapbutr, P; Maina, T; Malfait, F; Malfertheiner, MV; Malzert-Fréon, A; Mansouri, E; Mao, C; Marcellin, E; Marchiori, PER; Marcotte, DJ; Maréchal, A; Maric, N; Maris, JM; Maron, L; Marti, CN; Martínez-Milla, J; Mateo, J; Mather, K; Mathison, CJN; Matthay, MA; Maxwell, CL; Mazier, D; Mazumder, D; Mazurkiewicz, M; Mazzucchelli, TG; McAuley, DF; Mccoy, K; McVicar, DW; Mebel, AM; Mech, A; Meester, EJ; Meiselbach, H; Melero, I; Ménard, G; Meng, X; Mengya, Y; Merle, G; Meunier, B; Mfarrej, B; Mi, K; Migueliz, I; Mikuška, P; Miladi, K; Miletich, R; Millar, JE; Mills, MR; Milne, R; Minute, L; Misiak, M; Mo, F; Modi, A; Mok, F; Molina, C; Mollen, CJ; Molteni, V; Montalto, M; Montet, D; Monti, MC; Moor, MB; Moravec, P; Morsiani, C; Murillo, E; Murugan, P; Muslem, R; Myers, RK; N'guessan, FK; Nabil, H; Nadal, J; Nadeem, M; Nafady, MM; Nafie, MS; Nair, HP; Nakano, R; Nance, J; Naren, N; Neil, CJ; Nelson, J; Nery, FC; Netsch, C; Nguyen, TH; Ni, L; Ni, YX; Nie, W; Nielsen, LK; Nigam, K; Nikolayev, AA; Nishiyama, M; Niu, LL; Niu, PP; Nock, BA; Noer, PR; Noll, G; Noll, S; Norenberg, JP; Nowicka, J; Nutho, B; O'Connor, M; Obonyo, NG; Ochiai, T; Ochoa, MC; Oh, BL; Oh, S; Olczak, J; Olivares, X; Ommurugan, B; Oosthuizen, MC; Operario, D; Orešič, M; Oshima, K; Otano, I; Ou, Y; Owen, TW; Oxvig, C; Pacey, V; Pai, M; Paik, H; Paiva, R; Palmieri, EM; Palpant, N; Pan, L; Pan, Q; Panahi, S; Pang, B; Pang, ZC; Pannecouque, C; Paris, L; Park, D; Park, DJ; Park, E; Park, EC; Park, IH; Park, JH; Park, JI; Park, S; Passmore, MR; Pattaranggoon, NC; Paun, M; Pedersen, S; Pedron, J; Peng, M; Peng, X; Penzhorn, BL; Pérez-Camargo, D; Perez-Maldonado, R; Pérez-Vicente, C; Pham, TD; Pickering, L; Pickersgill, NA; Pinault, E; Pinotsis, N; Plan, M; Pocino, K; Poh, CL; Pons, EDC; Popoff, MR; Porri, D; Pourmand, A; Pratviel, G; Prudente, DO; Qi, H; Qi, N; Qian, LY; Qiao, L; Qiao, Q; Qin, QP; Qiu, N; Qiu, SW; Qu, F; Quan, M; Quigg, A; Raee, E; Raibaud, P; Ramanitrahasimbola, D; Rapoport, L; Rasby, RJ; Rasoanirina, BNV; Raspini, B; Ratner, JR; Razafindrakoto, Z; Redd, MA; Ren, H; Ren, N; Rey, J; Reynolds, CP; Rich, PR; Richards, CJ; Rigol, M; Rimoldi, S; Robert, P; Rodrigues, AE; Roe, JH; Rohde, S; Rokita, JL; Roland, J; Rombaut, L; Ronkainen, J; Rothenberg, SM; Roy, SC; Ruan, Z; Rucker, PV; Rueda, D; Ruhwald, M; Rungrotmongkol, T; Rupert, AS; Rusjan, P; Ryabov, AD; Rysä, J; Saad, NES; Sabioni, P; Sadow, PM; Sahai, N; Salem, HF; Salinas, B; Salonurmi, T; Samé Guerra, D; Sánchez, J; Sanchez-González, J; Sanmamed, MF; Sansores-Peraza, P; Santoro, JC; Santschi, PH; Saritas, T; Sarkisova, Y; Savolainen, MJ; Scherberich, JE; Schlom, DG; Schmelz, EM; Schmid, MC; Schneider, MP; Schumacher, S; Schwartz, JC; Schwartzer, JJ; Schwehr, K; Schweitzer, DH; Scott, ME; Sedky, NK; See Hoe, L; Sejian, V; Selvaraju, S; Sen, SK; Seo, G; Šerý, O; Settles, JA; Sfar, S; Shaffer, J; Shan, GL; Shang, Q; Shannahan, JH; Shao, B; Shao, H; Shao, J; Shao, ZH; Shasha, Y; Shaw, K; Sheeba, V; Shekar, K; Shen, G; Shen, H; Shen, XD; Shen, Y; Sherrell, PC; Shete, PB; Shi, AX; Shi, J; Shi, JH; Shi, S; Shi, X; Shigeta, Y; Shimbo, A; Shin, E; Sikka, N; Silhavy, TJ; Simanon, N; Simard, S; Simon, J; Simon, M; Simpson, SD; Simundic, AM; Since, M; Singh, B; Singhroy, DN; Sinisterra, OT; Smith, EH; Sobreira, TJP; Solanes, N; Somasundar, Y; Sommerer, C; Sonei, A; Song, B; Song, E; Song, J; Song, M; Song, Y; Soo Lee, M; Sorensen, MD; Sournia-Saquet, A; Spaepen, E; Spirk, D; Srivastava, S; Stancill, JS; Stanczak, PS; Starenki, D; Starr, F; Step, DL; Steubl, D; Stigliani, JL; Stráská, J; Sträter, N; Su, ZZ; Sudano, I; Suen, JY; Suh, HJ; Sui, ZY; Suico, JG; Suleiman, K; Sumon, K; Sun, HB; Sun, J; Sun, L; Sun, LL; Sun, M; Sun, Q; Sun, W; Sun, X; Sun, XF; Sun, Y; Sun, YB; Sun, YH; Sun, YN; Sun, Z; Sunada, K; Suzuki, S; Sylvan, JB; Takala, J; Talla, D; Tamir, Z; Tan, SJ; Tanda, S; Tang, H; Tang, J; Tang, LF; Tang, SJ; Tang, Y; Tao, FB; Tappel, R; Taratkin, M; Teijeira, Á; Tellew, JE; Thomas, AM; Thomas, SG; Thomson, SR; Tian, J; Tie, Y; Tirado, JL; Tolonen, A; Tosato, G; Tronnet, A; Tsai, S; Turtoi, A; Turtoi, E; Tvrdoňová, M; Tyagi, A; Tzou, DT; Uddin Ahmad, Z; Urias, E; Usawachintachit, M; Ustriyana, P; Utsumi, F; Vacca, M; Vaculovič, T; Vaidya, SS; Valentin, A; Valgepea, K; van den Berg, P; van den Bergh, JP; van der Heiden, K; van Gaalen, K; Van Gemert, W; van Haard, PMM; van Hest, JCM; Vecchiarelli, E; Večeřa, Z; Venkatesh, R; Verhaeghe, P; Verhagen, HJ; Vetter, JM; Vieira, D; Vilchez-Tschischke, JP; Villena-Gutierrez, R; Villoslada Terrones, V; Vital-Jacome, M; Voelkl, J; Vogel, K; Vogrin, S; Volke, D; von Bahr, V; Vysloužil, J; Wade, TL; Wagner-Gillespie, M; Walsh, SW; Wan, LJ; Wan, SP; Wang, AL; Wang, B; Wang, BY; Wang, C; Wang, D; Wang, F; Wang, H; Wang, HR; Wang, HY; Wang, J; Wang, JY; Wang, K; Wang, L; Wang, LF; Wang, P; Wang, Q; Wang, R; Wang, SF; Wang, SP; Wang, SR; Wang, T; Wang, W; Wang, WP; Wang, X; Wang, XJ; Wang, Y; Wang, YL; Wang, YN; Wáng, YXJ; Wang, Z; Wang, ZF; Wang, ZY; Waning, B; Warner, JM; Washington, SL; Watson, AK; Wei, B; Wei, C; Wei, F; Wei, X; Wei, Y; Wemhoff, AP; Wen, Z; Weng, TT; Wesdemiotis, C; Wheeler, DA; Wildner, M; Wilson, BK; Wirth, LJ; Wissler, M; Wu, F; Wu, G; Wu, J; Wu, KH; Wu, MC; Wu, P; Wu, PK; Wu, S; Wu, W; Wu, X; Wu, XP; Wu, Y; Wyatt, E; Wyllie, S; Xia, Y; Xiao, BH; Xiao, SZ; Xiao, W; Xiao, X; Xiao, Z; Xie, D; Xie, K; Xie, X; Xie, Y; Xie, YF; Xin, S; Xin, Z; Xing, Q; Xing, WQ; Xiong, D; Xiong, X; Xu, C; Xu, D; Xu, F; Xu, G; Xu, H; Xu, J; Xu, JY; Xu, L; Xu, N; Xu, W; Xu, X; Xu, Y; Xu, YM; Xue, H; Xue, J; Xue, Z; Yan, R; Yan, SQ; Yan, W; Yan, X; Yan, Z; Yang, C; Yang, D; Yang, F; Yang, FC; Yang, G; Yang, J; Yang, M; Yang, P; Yang, Q; Yang, R; Yang, S; Yang, SJ; Yang, TWW; Yang, X; Yang, Y; Yang, Z; Yao, C; Yao, L; Yao, LP; Yao, M; Yao, T; Yao, W; Yao, Y; Yaseen, T; Yazdani, V; Ye, J; Ye, S; Yerys, BE; Yi, HWL; Yi, JL; Yin, F; Yin, J; Yin, Y; Yin, Z; Yong, ZP; Yongli, S; Yoo, JS; Yoshikawa, N; You, Q; Yu, B; Yu, CQ; Yu, H; Yu, HG; Yu, J; Yu, L; Yu, Q; Yu, X; Yu, Y; Yu, YK; Yu, Z; Yuan, Q; Yuan, R; Yuan, W; Yuan, X; Yuan, Y; Zager, RA; Zagozdzon, A; Zaller, N; Zang, YP; Zappi, ME; Zelikoff, JT; Zeman, T; Zhai, X; Zhan, P; Zhang, B; Zhang, C; Zhang, G; Zhang, H; Zhang, HB; Zhang, J; Zhang, JS; Zhang, L; Zhang, M; Zhang, Q; Zhang, RX; Zhang, S; Zhang, T; Zhang, W; Zhang, WH; Zhang, X; Zhang, XX; Zhang, Y; Zhang, YQ; Zhang, YW; Zhang, Z; Zhang, ZH; Zhao, D; Zhao, FL; Zhao, K; Zhao, L; Zhao, M; Zhao, R; Zhao, S; Zhao, W; Zhao, WG; Zhao, X; Zhao, Y; Zheng, G; Zheng, J; Zheng, S; Zheng, W; Zheng, Y; Zheng, YG; Zhong, Z; Zhou, C; Zhou, D; Zhou, H; Zhou, HY; Zhou, L; Zhou, Q; Zhou, X; Zhou, Y; Zhou, YL; Zhou, Z; Zhu, J; Zhu, L; Zhu, N; Zhu, X; Zhu, XF; Zhu, Y; Zhu, Z | 1 |
| Brøsen, K; Bøtker, HE; Dollerup, OL; Frøkiær, J; Hansson, NH; Jespersen, NR; Jessen, N; Larsen, AH; Møller, N; Nørrelund, H; Wiggers, H | 1 |
| Benes, J; Borlaug, BA; Franekova, J; Kovar, J; Melenovsky, V; Pelikanova, T; Segetova, M; Tura, A | 1 |
| Eckel, RH; Koh, KK; Lim, S | 1 |
| Adachi, H; Murata, M; Nakade, T; Oshima, S | 1 |
| Hernández-Cascales, J | 1 |
| Javor, E; Lucijanic, M; Skelin, M | 1 |
| Bertero, E; Heymans, S; Maack, C; Sequeira, V | 1 |
| Ceriello, A; Genovese, S; Gronda, E; Mannucci, E | 1 |
| Bøtker, H; Frandsen, E; Halbirk, M; Holst, JJ; Møller, N; Nielsen, R; Nielsen, S; Nørrelund, H; Schmitz, O; Wiggers, H | 1 |
| Doverspike, A; Elahi, D; Hentosz, T; Huerbin, R; Nikolaidis, LA; Shannon, RP; Shen, YT; Stolarski, C; Zourelias, L | 1 |
| Taegtmeyer, H | 1 |
| Gutniak, M; Malmberg, K; Olsson, A; Rydén, L; Thrainsdottir, I | 1 |
| Clauss, RH; Dumont, AE; Witte, CL | 1 |
| Opie, LH | 1 |
| Serbin, VI; Studenikin, MIa | 1 |
| Adrian, TE; Bloom, SR; Clark, AJ; McMichael, HB | 1 |
| Alfiero, R; Cocco, G; Padula, A; Rizzo, A; Strozzi, C; Tasini, MT; Urso, L | 1 |
| Cocco, G; Sfrisi, C | 1 |
| Le Jemtel, TH; Maskin, CS; Sonnenblick, EH | 1 |
| Arem, R; Field, JB; Garber, AJ | 1 |
| Pimenov, LT; Trusov, VV | 1 |
| Sivkov, II | 1 |
| Burian, EF; Iatsenko, IV; Kukes, VG; Sivkov, SI; Tsoĭ, AN | 1 |
| Guillet, R; Stevens, TP | 1 |
| Bell, N; Buchanan, KD; Elborn, JS; Nicholls, DP; Riley, M; Stanford, CF | 1 |
| Buchanan, KD; Elborn, JS; McDowell, G; Nicholls, DP; Nugent, AM; Onuoha, GN; Riley, MS; Shaw, C; Steele, IC | 1 |
| Stoddart, JC | 1 |
| Newman, WH | 1 |
| Breithardt, G; Jaeschke, M; Kuhn, H; Loogen, F | 1 |
| Breithardt, G; Jaeschke, M; Kuhn, H | 1 |
| Chiche, P; Haiat, R; Tarrade, T; Witchitz, S | 1 |
| Clark, DR; Jenkins, WL | 1 |
| Bollati, C; Bruni, B; Gamba, S; Turbiglio, PC | 1 |
| Golikov, AP; Riabinin, VA | 1 |
| Stryjek-Kamińska, D | 1 |
| Kleinberger, G; Lochs, H; Magometschnigg, D; Pall, H; Pichler, M | 1 |
| Hayler, AM; Holt, DW; Medd, RK; O'Keeffe, B | 1 |
| Apitz, J | 1 |
| Castaldi, C; D'Amore, F; Materia, E; Mauceri, M; Rivosecchi, L | 1 |
| Sivkov, SI | 1 |
| Jablońska-Ulbrych, A; Uszyńska, H; Wróblewska, B; Zytkiewicz, A | 1 |
| Dubiel, J; Pyzik, Z; Szczeklik, J | 1 |
| Bertolazzi, R; Marenco, G; Ricciardi, S | 1 |
| Favilli, R; Gragnoli, G; Martinelli, G; Nami, R; Palazzuoli, V; pallassini, A; Tanganelli, I | 1 |
| Nelius, D | 1 |
| Bosello, O; Cigolini, M; Rossi, G | 1 |
| Kozlowska, F; Krug, H; Szmydt, W | 1 |
| Buniatian, AA; Meshcheriakov, AV; Sandrikov, VA; Trekova, NA; Tumasov, VM | 1 |
| Cibor, E; Dubiel, JP; Dubiel, JS; Pyzik, A; Szczeklik, J | 1 |
| Leo, P; Netter, R; Sanna, S | 1 |
| Artese, D; Di Nicola, A; Santilli, S | 1 |
| Aogaichi, K; Keren, G; LeJemtel, TH; Mancini, DM; Sonnenblick, EH | 1 |
| Braunwald, E; Colucci, WS; Wright, RF | 1 |
| Iacono, A | 1 |
| Aryanpur, I | 1 |
| Gunnar, RM; Loeb, HS; Rahimtoola, SH | 1 |
| Riecker, G | 1 |
| Brogan, E; Kozonis, MC; Overy, DC | 1 |
| Stutz, DR | 1 |
| Fletcher, E; Lal, S | 1 |
| Brogan, E | 1 |
| Lvoff, R; Wilcken, DE | 2 |
| Bertrand, ME; Carre, A; Delbecque, H; Ducloux, G; Ginestet, A; Ketelers, JY; Pauchant, M; Waremboug, H | 1 |
| Strauer, BE | 2 |
| Goodwin, JF | 1 |
| Entman, M; Epstein, SE; Levey, GS; Skelton, CL | 1 |
| Epstein, SE; Levey, GS; Prindle, KH | 1 |
| Andersen, HT | 1 |
| Kones, RJ | 3 |
| Bruni, B | 1 |
| Caio, M; Govoni, P; Vancini, B | 1 |
| Gabe, I; Jewitt, D; Maurer, B; Mills, C; Shillingford, J; Thomas, M | 1 |
| Evans, GT; Scheinman, MM | 1 |
| Schröder, R | 1 |
| Likoff, W | 1 |
| Hosoda, S | 1 |
| Williams, JF | 2 |
| Pawliszewska, J; Puchalska-Krotki, H; Szachowski, J | 1 |
| Kaindl, F; Kohn, P | 1 |
| Peräsalo, J | 1 |
| Guerricchio, G | 2 |
| Keck, EW | 1 |
| Chudiková, J; Plachá, L; Riecanský, I | 1 |
| Avenhaus, H; Lüderitz, B | 1 |
| Kaindl, F; Kühn, P | 1 |
| Holzhey, P; Kaindl, F; Kühn, P; Niederberger, M | 1 |
| Tschirdewahn, B | 1 |
| Del Giallo, P; Lombardi, M; Magini, G; Valiensi, M | 1 |
| Amsterdam, EA; King, JF; Mason, DT; Massumi, RA; Salel, AF; Zelis, R | 1 |
| Lambotte, L; Rocmans, P | 1 |
| Bomanto, B; Bossi, M; Lotto, A; Rota, M; Sanna, GP | 1 |
| Kirsch, M; Lucchesi, BR; Nobel-Allen, N | 1 |
| Falch, D; Forfang, K; Fremstad, D; Frey, HM | 1 |
| Almici, C; Inzoli, MR | 1 |
| Gagossi, M | 1 |
| Kühn, P | 1 |
| De Thomatis, M | 1 |
| Bellinghieri, G; Ceruso, D; D'Andrea-Petrelli, L; Frisina, N; Squadrito, G | 1 |
| Battaglia, A; Gnoffo, R; Mercurio, G; Profeta, F; Raineri, A | 1 |
| Abdrakhmanov, VR; Berestov, AA; Bobkov, AI; Golikov, AP | 1 |
| Hinterberger, H; Wilcken, DE | 1 |
| Glick, G; Parmley, WW; Sonnenblick, EH | 1 |
| Foley, RE | 1 |
| Pippig, L | 1 |
| Fontanes, AL; Nord, HJ; Williams, JF | 1 |
| Allen, HN; Danzig, R; Forrester, JS; Swan, HJ | 1 |
| Armstrong, PW; Austen, WG; Daggett, WM; Gold, HK; Sanders, CA | 1 |
| Gavrilesco, S; Pop, T; Streian, C | 1 |
| Glick, G | 1 |
| Gavrilescu, S; Streian, C | 2 |
| Huhti, E; Koivisto, O; Oilinki, O; Takkunen, J; Vuopala, U | 1 |
| Falch, D; Forfang, K; Fremstad, D; Frey, HM; Norman, N | 1 |
| Capri, C | 1 |
| Cotoi, S; Gavrilescu, S; Pop, T | 1 |
| Berchthold, P; Franke, F; Simon, H | 1 |
| Danzig, R; Diamond, G; Forrester, J; Parmley, WW; Swan, HJ | 2 |
| Beiser, GD; Epstein, SE; Glancy, DL; Goldstein, RE; Levey, GS; Skelton, CL | 1 |
| Hermann, HJ; Meyers, SN; Sanmarco, ME | 1 |
| Celentano, V; De Ninno, F; Giugliano, F | 1 |
| Bossi, M; Lomanto, B; Lotto, A; Sanna, GP | 1 |
| Hammerl, H; Henk, W; Köhn, H; Kränzl, C; Pichler, O; Studlar, M | 1 |
| Berchtold, P; Esser, H; Franke, F; Fricke, G; Simon, H; Wardack, A | 1 |
| Funovics, J; Wolner, E | 1 |
| Congdon, EE; Vixie, DK; Wright, MF | 1 |
| Humair, L; Robert, M | 2 |
| Bing, RJ; Puri, PS | 1 |
| Bing, RJ; Cowan, CM; Goldschlager, N; Leb, G; Robin, E | 1 |
| Frye, RL; Greenberg, BH; Moffitt, EA; Tsakiris, AG | 1 |
| Reynolds, EW; Vander Ark, CR | 1 |
| Dolgin, M | 1 |
| Binnion, PF; Fletcher, E; Hutchison, KJ; Lal, S; Murtagh, JG | 1 |
| Epstein, SE; Gold, HK; Levey, GS; Prindle, KH | 1 |
| Woolf, PD | 1 |
| Dekoninck, WJ | 1 |
| Chuck, L; Matloff, J; Parmley, WW | 1 |
| Cronk, JD | 1 |
| Goldberg, LI; Simanis, J | 1 |
| Kones, RJ; Phillips, JH | 1 |
| Parmley, WW | 1 |
| Hulsey, R | 1 |
| Glick, G; Parmley, WW; Sonnenblick, EH; Wechsler, AS | 1 |
29 review(s) available for glucagon and Cardiac Failure
| Article | Year |
|---|---|
The use of glucagon-like-peptide-1 receptor agonist in the cardiology practice.
Topics: Atherosclerosis; Cardiology; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glucagon; Glucose; Heart Failure; Humans; Hypoglycemic Agents; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 Inhibitors | 2023 |
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Clinical implications of current cardiovascular outcome trials with sodium glucose cotransporter-2 (SGLT2) inhibitors.
Topics: Albuminuria; Atherosclerosis; Benzhydryl Compounds; Body Weight; Canagliflozin; Cardiovascular Diseases; Cardiovascular System; Glucagon; Glucagon-Like Peptides; Glucosides; Heart Failure; Hemodynamics; Humans; Hypoglycemic Agents; Ketones; Lipids; Liraglutide; Metabolic Syndrome; Metformin; Non-alcoholic Fatty Liver Disease; Osmosis; Risk Factors; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome | 2018 |
Glucagon and heart in type 2 diabetes: new perspectives.
Topics: Animals; Benzhydryl Compounds; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glucagon; Glucosides; Heart; Heart Failure; Humans; Hypoglycemic Agents; Liraglutide; Myocardium; Risk Factors; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome | 2016 |
[Old and new positive inotropic drugs: problems and controversies].
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Aminopyridines; Amrinone; Cardiotonic Agents; Glucagon; Glucosides; Heart Failure; Histamine; Humans; Imidazoles; Inosine; Quinazolines; Xanthines | 1984 |
[Positive inotropic therapy of cardiac failure: old and new drugs, controversies and tests].
Topics: Aminopyridines; Amrinone; Cardiac Glycosides; Cardiotonic Agents; Glucagon; Heart Failure; Histamine; Humans; Imidazoles; Inosine; Phosphodiesterase Inhibitors; Quinazolines; Sympathomimetics | 1984 |
Neuroendocrine changes in chronic cardiac failure.
Topics: Atrial Natriuretic Factor; Bombesin; Chronic Disease; Glucagon; Heart Failure; Humans; Insulin; Neuropeptide Y; Neurosecretory Systems; Neurotensin; Renin-Angiotensin System | 1996 |
Fluid balance and acute cardiovascular failure.
Topics: Adenosine Triphosphate; Adrenal Cortex Hormones; Adrenergic alpha-Antagonists; Bedding and Linens; Catecholamines; Glucagon; Gravity Suits; Heart Failure; Humans; Monitoring, Physiologic; Oxygen Inhalation Therapy; Plasma Substitutes; Respiratory Insufficiency; Shock, Cardiogenic; Shock, Septic; Sympathomimetics; Water-Electrolyte Balance | 1978 |
A review of drugs affecting the heart.
Topics: Anesthetics; Animals; Arrhythmias, Cardiac; Calcium; Catecholamines; Cats; Digitalis Glycosides; Diuretics; Dog Diseases; Dogs; Glucagon; Heart; Heart Failure; Lidocaine; Liver; Myocardial Contraction; Phenytoin; Potassium; Propranolol; Prostaglandins; Quinidine; Vitamin E; Xanthines; Xylazine | 1977 |
[Clinical use of glucagon].
Topics: Acute Disease; Adrenal Gland Neoplasms; Glucagon; Heart Failure; Humans; Hypoglycemia; Pancreatitis; Pheochromocytoma; Shock, Cardiogenic | 1979 |
[Glucagon : recent acquisitions, with special reference to its metabolic effects and use in diagnosis and therapy].
Topics: Acute Kidney Injury; Amino Acids; Animals; Arthritis, Rheumatoid; Catecholamines; Diabetes Mellitus; Diabetic Coma; Glucagon; Growth Hormone; Heart Failure; Humans; Hypoglycemia; Insulin; Insulin Secretion; Islets of Langerhans; Lipid Metabolism; Metabolism; Minerals; Pancreatitis; Pheochromocytoma | 1975 |
Inotropic drugs for the treatment of heart failure.
Topics: Adrenergic alpha-Agonists; Calcium; Cardiotonic Agents; Catecholamines; Glucagon; Heart Failure; Histamine; Humans; Injections, Intravenous; Myocardial Contraction; Regional Blood Flow; Xanthines | 1985 |
New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.
Topics: Adenylyl Cyclases; Adrenergic alpha-Agonists; Calcium; Cardiotonic Agents; Cyclic AMP; Dobutamine; Dopamine; Drug Tolerance; Glucagon; Heart Failure; Histamine; Humans; Levodopa; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Receptors, Adrenergic; Receptors, Adrenergic, beta; Stimulation, Chemical; Sympathomimetics; Theophylline; Xanthines | 1986 |
[Inotropic drugs in the treatment of heart failure].
Topics: Adrenergic beta-Agonists; Digitalis Glycosides; Glucagon; Heart Failure; Humans; Xanthines | 1987 |
The failing myocardium. I. Drug management.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Atropine; Blood Pressure; Blood Volume; Cardiac Output; Digitalis Glycosides; Dopamine; Female; Glucagon; Heart Failure; Humans; Isoproterenol; Male; Middle Aged; Myocardial Infarction; Norepinephrine; Ouabain; Plasma Substitutes; Shock, Cardiogenic | 1973 |
Adenyl cyclase and myocardial contractility.
Topics: Adenine Nucleotides; Adenylyl Cyclases; Animals; Catecholamines; Cats; Cyclic AMP; Enzymes; Epinephrine; Glucagon; Heart; Heart Failure; Microsomes; Muscle Contraction; Myocardium; Propranolol; Thyroid Hormones | 1970 |
[Glucagon--a therapeutic alternative in heart failure?].
Topics: Adenylyl Cyclases; Animals; Blood Circulation; Cyclic AMP; Dogs; Glucagon; Heart; Heart Failure; Humans; Liver; Phosphotransferases; Propranolol; Rats; Time Factors | 1971 |
The molecular and ionic basis of altered myocardial contractility.
Topics: Adenylyl Cyclases; Biological Transport, Active; Calcium; Catecholamines; Chemical Phenomena; Chemistry; Cyclic AMP; Digitalis Glycosides; Energy Metabolism; Glucagon; Heart; Heart Failure; Male; Models, Biological; Myocardium; Potassium; Receptors, Adrenergic; Sarcoplasmic Reticulum; Sodium; Thyroid Hormones; Ventricular Function | 1973 |
Treatment of the failing heart independent of digitalis or its glycosides.
Topics: Amiloride; Cardiac Output; Diet; Digitalis Glycosides; Diuretics; Glucagon; Heart Failure; Humans; Hypokalemia; Organomercury Compounds; Sodium; Stress, Psychological; Sympathomimetics | 1972 |
[Heart failure caused by sclerotic coronary diseases and hypertension and its management].
Topics: Angina Pectoris; Arrhythmias, Cardiac; Chronic Disease; Coronary Disease; Digitalis Glycosides; Diuretics; Electrocardiography; Glucagon; Glucocorticoids; Heart Failure; Humans; Hypertension; Myocardial Infarction; Radiography | 1972 |
[Criteria for the evaluation of myocardial contractility of the hypertrophied and insufficient heart. II].
Topics: Action Potentials; Animals; Aortic Valve Insufficiency; Blood Pressure; Cardiac Catheterization; Cardiac Glycosides; Cardiac Volume; Cats; Glucagon; Guinea Pigs; Heart; Heart Conduction System; Heart Failure; Heart Function Tests; Heart Ventricles; Hemodynamics; Lidocaine; Mitral Valve Insufficiency; Muscle Contraction; Oxygen Consumption; Papillary Muscles; Propranolol; Pulmonary Valve Insufficiency; Rabbits | 1973 |
New developments and therapeutic applications of cardiac stimulating agents.
Topics: Cardiac Output; Catecholamines; Digitalis Glycosides; Digitoxin; Digoxin; Dopamine; Glucagon; Heart; Heart Failure; Humans; Isoproterenol; Myocardial Infarction; Norepinephrine | 1973 |
[Circulatory failure refractory to treatment].
Topics: Blood Transfusion; Digitalis Glycosides; Diuretics; Dopamine; Glucagon; Heart Failure; Humans; Isoproterenol; Methods; Peritoneal Dialysis; Posture; Renal Dialysis | 1974 |
[Treatment of chronic heart failure].
Topics: Arrhythmias, Cardiac; Cardiac Glycosides; Chronic Disease; Digitalis Glycosides; Diuretics; Glucagon; Heart Conduction System; Heart Failure; Hemodynamics; Humans; Methods | 1972 |
[Treatment of heart failure].
Topics: Digitalis Glycosides; Diuretics; Drug Therapy, Combination; Glucagon; Glucose; Heart Failure; Humans; Insulin; Potassium; Theophylline; Water-Electrolyte Balance | 1974 |
The management of acute pulmonary edema.
Topics: Acute Disease; Cardiac Glycosides; Diuretics; Emergencies; Glucagon; Heart Failure; Humans; Morphine; Oxygen Inhalation Therapy; Posture; Pulmonary Edema | 1969 |
Glucagon and the cardiovascular system.
Topics: Blood Circulation; Cardiac Output; Cardiovascular System; Chronic Disease; Electrophysiology; Glucagon; Heart; Heart Failure; Humans; Muscle Contraction; Myocardium; Nausea; Sympathomimetics; Vascular Resistance; Vomiting | 1969 |
[Treatment of acute myocardial infarct].
Topics: Acidosis; Analgesics; Arrhythmias, Cardiac; Cardiac Glycosides; Dextrans; Diuretics; Glucagon; Glucocorticoids; Heart Failure; Humans; Myocardial Infarction; Oxygen Inhalation Therapy; Potassium; Pulmonary Edema; Rest; Shock; Streptokinase; Time Factors; Tranquilizing Agents; Vasodilator Agents | 1970 |
Power failure in acute myocardial infarction.
Topics: Angiocardiography; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Assisted Circulation; Blood Pressure; Cardiac Output; Digitalis Glycosides; Dopamine; Glucagon; Heart Failure; Heart Rate; Hemodynamics; Humans; Isoproterenol; Lung; Myocardial Infarction; Norepinephrine; Prognosis; Pulmonary Circulation; Regional Blood Flow; Vascular Resistance | 1970 |
12 trial(s) available for glucagon and Cardiac Failure
| Article | Year |
|---|---|
Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Adenine; Adenocarcinoma; Adipogenesis; Administration, Cutaneous; Administration, Ophthalmic; Adolescent; Adsorption; Adult; Aeromonas hydrophila; Aerosols; Aged; Aged, 80 and over; Aging; Agriculture; Air Pollutants; Air Pollution; Airway Remodeling; Alanine Transaminase; Albuminuria; Aldehyde Dehydrogenase 1 Family; Algorithms; AlkB Homolog 2, Alpha-Ketoglutarate-Dependent Dioxygenase; Alzheimer Disease; Amino Acid Sequence; Ammonia; Ammonium Compounds; Anaerobiosis; Anesthetics, Dissociative; Anesthetics, Inhalation; Animals; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Monoclonal, Humanized; Antifungal Agents; Antigens, Bacterial; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antitubercular Agents; Antiviral Agents; Apolipoproteins E; Apoptosis; Arabidopsis; Arabidopsis Proteins; Arsenic; Arthritis, Rheumatoid; Asthma; Atherosclerosis; ATP-Dependent Proteases; Attitude of Health Personnel; Australia; Austria; Autophagy; Axitinib; Bacteria; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Toxins; Bacterial Typing Techniques; Bariatric Surgery; Base Composition; Bayes Theorem; Benzoxazoles; Benzylamines; beta Catenin; Betacoronavirus; Betula; Binding Sites; Biological Availability; Biological Oxygen Demand Analysis; Biomarkers; Biomarkers, Tumor; Biopsy; Bioreactors; Biosensing Techniques; Birth Weight; Blindness; Blood Chemical Analysis; Blood Gas Analysis; Blood Glucose; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Blood-Brain Barrier; Blotting, Western; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Borates; Brain; Brain Infarction; Brain Injuries, Traumatic; Brain Neoplasms; Breakfast; Breast Milk Expression; Breast Neoplasms; Bronchi; Bronchoalveolar Lavage Fluid; Buffaloes; Cadherins; Calcification, Physiologic; Calcium Compounds; Calcium, Dietary; Cannula; Caprolactam; Carbon; Carbon Dioxide; Carboplatin; Carcinogenesis; Carcinoma, Ductal; Carcinoma, Ehrlich Tumor; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Pancreatic Ductal; Carcinoma, Renal Cell; Cardiovascular Diseases; Carps; Carrageenan; Case-Control Studies; Catalysis; Catalytic Domain; Cattle; CD8-Positive T-Lymphocytes; Cell Adhesion; Cell Cycle Proteins; Cell Death; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Phone Use; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cell Transformation, Viral; Cells, Cultured; Cellulose; Chemical Phenomena; Chemoradiotherapy; Child; Child Development; Child, Preschool; China; Chitosan; Chlorocebus aethiops; Cholecalciferol; Chromatography, Liquid; Circadian Clocks; Circadian Rhythm; Circular Dichroism; Cisplatin; Citric Acid; Clinical Competence; Clinical Laboratory Techniques; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Clostridioides difficile; Clostridium Infections; Coculture Techniques; Cohort Studies; Cold Temperature; Colitis; Collagen Type I; Collagen Type I, alpha 1 Chain; Collagen Type XI; Color; Connective Tissue Diseases; Copper; Coronary Angiography; Coronavirus 3C Proteases; Coronavirus Infections; Cost of Illness; Counselors; COVID-19; COVID-19 Testing; Creatine Kinase; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Cryoelectron Microscopy; Cryosurgery; Crystallography, X-Ray; Cues; Cultural Competency; Cultural Diversity; Curriculum; Cyclic AMP Response Element-Binding Protein; Cyclin-Dependent Kinase Inhibitor p21; Cycloparaffins; Cysteine Endopeptidases; Cytokines; Cytoplasm; Cytoprotection; Databases, Factual; Denitrification; Deoxycytidine; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diagnosis, Differential; Diatoms; Diet; Diet, High-Fat; Dietary Exposure; Diffusion Magnetic Resonance Imaging; Diketopiperazines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Disease Progression; Disease-Free Survival; DNA; DNA Damage; DNA Glycosylases; DNA Repair; DNA-Binding Proteins; DNA, Bacterial; DNA, Viral; Docetaxel; Dose Fractionation, Radiation; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drosophila; Drosophila melanogaster; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Repositioning; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Edema; Edible Grain; Education, Graduate; Education, Medical, Graduate; Education, Pharmacy; Ehlers-Danlos Syndrome; Electron Transport Complex III; Electron Transport Complex IV; Electronic Nicotine Delivery Systems; Emergency Service, Hospital; Empathy; Emulsions; Endothelial Cells; Endurance Training; Energy Intake; Enterovirus A, Human; Environment; Environmental Monitoring; Enzyme Assays; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Epoxide Hydrolases; Epoxy Compounds; Erythrocyte Count; Erythrocytes; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Esophagectomy; Estrogens; Etanercept; Ethiopia; Ethnicity; Ethylenes; Exanthema; Exercise; Exercise Test; Exercise Tolerance; Extracellular Matrix; Extracorporeal Membrane Oxygenation; Eye Infections, Fungal; False Negative Reactions; Fatty Acids; Fecal Microbiota Transplantation; Feces; Female; Femur Neck; Fermentation; Ferritins; Fetal Development; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Fibroins; Fish Proteins; Flavanones; Flavonoids; Focus Groups; Follow-Up Studies; Food Handling; Food Supply; Food, Formulated; Forced Expiratory Volume; Forests; Fractures, Bone; Fruit and Vegetable Juices; Fusobacteria; G1 Phase Cell Cycle Checkpoints; G2 Phase Cell Cycle Checkpoints; Gamma Rays; Gastrectomy; Gastrointestinal Microbiome; Gastrointestinal Stromal Tumors; Gefitinib; Gels; Gemcitabine; Gene Amplification; Gene Expression; Gene Expression Regulation; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Plant; Gene Knockdown Techniques; Gene-Environment Interaction; Genotype; Germany; Glioma; Glomerular Filtration Rate; Glucagon; Glucocorticoids; Glycemic Control; Glycerol; Glycogen Synthase Kinase 3 beta; Glycolipids; Glycolysis; Goblet Cells; Gram-Negative Bacterial Infections; Granulocyte Colony-Stimulating Factor; Graphite; Greenhouse Effect; Guanidines; Haemophilus influenzae; HCT116 Cells; Health Knowledge, Attitudes, Practice; Health Personnel; Health Services Accessibility; Health Services Needs and Demand; Health Status Disparities; Healthy Volunteers; Heart Failure; Heart Rate; Heart Transplantation; Heart-Assist Devices; HEK293 Cells; Heme; Heme Oxygenase-1; Hemolysis; Hemorrhage; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Hexoses; High-Throughput Nucleotide Sequencing; Hippo Signaling Pathway; Histamine; Histamine Agonists; Histidine; Histone Deacetylase 2; HIV Infections; HIV Reverse Transcriptase; HIV-1; Homebound Persons; Homeodomain Proteins; Homosexuality, Male; Hospice and Palliative Care Nursing; HSP70 Heat-Shock Proteins; Humans; Hyaluronan Receptors; Hydrogen; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrolysis; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemia; Hypoglycemic Agents; Hypoxia; Idiopathic Interstitial Pneumonias; Imaging, Three-Dimensional; Imatinib Mesylate; Immunotherapy; Implementation Science; Incidence; INDEL Mutation; Induced Pluripotent Stem Cells; Industrial Waste; Infant; Infant, Newborn; Inflammation; Inflammation Mediators; Infliximab; Infusions, Intravenous; Inhibitory Concentration 50; Injections; Insecticides; Insulin-Like Growth Factor Binding Protein 5; Insulin-Secreting Cells; Interleukin-1; Interleukin-17; Interleukin-8; Internship and Residency; Intestines; Intracellular Signaling Peptides and Proteins; Ion Transport; Iridaceae; Iridoid Glucosides; Islets of Langerhans Transplantation; Isodon; Isoflurane; Isotopes; Italy; Joint Instability; Ketamine; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Kidney Neoplasms; Kinetics; Klebsiella pneumoniae; Knee Joint; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Lactate Dehydrogenase 5; Laparoscopy; Laser Therapy; Lasers, Semiconductor; Lasers, Solid-State; Laurates; Lead; Leukocyte L1 Antigen Complex; Leukocytes, Mononuclear; Light; Lipid Peroxidation; Lipopolysaccharides; Liposomes; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Locomotion; Longitudinal Studies; Lopinavir; Lower Urinary Tract Symptoms; Lubricants; Lung; Lung Diseases, Interstitial; Lung Neoplasms; Lymphocyte Activation; Lymphocytes, Tumor-Infiltrating; Lymphoma, Mantle-Cell; Lysosomes; Macrophages; Male; Manganese Compounds; MAP Kinase Kinase 4; Mass Screening; Maternal Health; Medicine, Chinese Traditional; Melanoma, Experimental; Memantine; Membrane Glycoproteins; Membrane Proteins; Mesenchymal Stem Cell Transplantation; Metal Nanoparticles; Metalloendopeptidases; Metalloporphyrins; Methadone; Methane; Methicillin-Resistant Staphylococcus aureus; Mexico; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Mice, Nude; Mice, SCID; Mice, Transgenic; Microarray Analysis; Microbial Sensitivity Tests; Microbiota; Micronutrients; MicroRNAs; Microscopy, Confocal; Microsomes, Liver; Middle Aged; Milk; Milk, Human; Minority Groups; Mitochondria; Mitochondrial Membranes; Mitochondrial Proteins; Models, Animal; Models, Molecular; Molecular Conformation; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Epidemiology; Molecular Structure; Molecular Weight; Multilocus Sequence Typing; Multimodal Imaging; Muscle Strength; Muscle, Skeletal; Muscular Diseases; Mutation; Mycobacterium tuberculosis; Myocardial Stunning; Myristates; NAD(P)H Dehydrogenase (Quinone); Nanocomposites; Nanogels; Nanoparticles; Nanotechnology; Naphthalenes; Nasal Cavity; National Health Programs; Necrosis; Needs Assessment; Neoadjuvant Therapy; Neonicotinoids; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Netherlands; Neuroblastoma; Neuroprotective Agents; Neutrophils; NF-kappa B; NFATC Transcription Factors; Nicotiana; Nicotine; Nitrates; Nitrification; Nitrites; Nitro Compounds; Nitrogen; Nitrogen Dioxide; North Carolina; Nuclear Magnetic Resonance, Biomolecular; Nuclear Proteins; Nucleic Acid Hybridization; Nucleosomes; Nutrients; Obesity; Obesity, Morbid; Oceans and Seas; Oncogene Protein v-akt; Oncogenes; Oocytes; Open Reading Frames; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporosis, Postmenopausal; Outpatients; Ovarian Neoplasms; Ovariectomy; Overweight; Oxazines; Oxidants; Oxidation-Reduction; Oxidative Stress; Oxides; Oxidoreductases; Oxygen; Oxygen Inhalation Therapy; Oxygenators, Membrane; Ozone; Paclitaxel; Paenibacillus; Pain Measurement; Palliative Care; Pancreatic Neoplasms; Pandemics; Parasympathetic Nervous System; Particulate Matter; Pasteurization; Patient Preference; Patient Satisfaction; Pediatric Obesity; Permeability; Peroxiredoxins; Peroxynitrous Acid; Pharmaceutical Services; Pharmacists; Pharmacy; Phaseolus; Phenotype; Phoeniceae; Phosphates; Phosphatidylinositol 3-Kinases; Phospholipid Transfer Proteins; Phospholipids; Phosphorus; Phosphorylation; Photoperiod; Photosynthesis; Phylogeny; Physical Endurance; Physicians; Pilot Projects; Piperidines; Pituitary Adenylate Cyclase-Activating Polypeptide; Plant Extracts; Plant Leaves; Plant Proteins; Plant Roots; Plaque, Atherosclerotic; Pneumonia; Pneumonia, Viral; Point-of-Care Testing; Polyethylene Glycols; Polymers; Polysorbates; Pore Forming Cytotoxic Proteins; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Poverty; Pre-Exposure Prophylaxis; Prediabetic State; Predictive Value of Tests; Pregnancy; Pregnancy Trimester, First; Pregnancy, High-Risk; Prenatal Exposure Delayed Effects; Pressure; Prevalence; Primary Graft Dysfunction; Primary Health Care; Professional Role; Professionalism; Prognosis; Progression-Free Survival; Prolactin; Promoter Regions, Genetic; Proof of Concept Study; Proportional Hazards Models; Propylene Glycol; Prospective Studies; Prostate; Protein Binding; Protein Biosynthesis; Protein Isoforms; Protein Kinase Inhibitors; Protein Phosphatase 2; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Proteome; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Proto-Oncogene Proteins c-ret; Proto-Oncogene Proteins p21(ras); Proton Pumps; Protons; Protoporphyrins; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pulmonary Artery; Pulmonary Disease, Chronic Obstructive; Pulmonary Gas Exchange; Pulmonary Veins; Pyrazoles; Pyridines; Pyrimidines; Qualitative Research; Quinoxalines; Rabbits; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Histamine H3; Receptors, Immunologic; Receptors, Transferrin; Recombinant Proteins; Recurrence; Reference Values; Referral and Consultation; Regional Blood Flow; Registries; Regulon; Renal Insufficiency, Chronic; Reperfusion Injury; Repressor Proteins; Reproducibility of Results; Republic of Korea; Research Design; Resistance Training; Respiration, Artificial; Respiratory Distress Syndrome; Respiratory Insufficiency; Resuscitation; Retinal Dehydrogenase; Retreatment; Retrospective Studies; Reverse Transcriptase Inhibitors; Rhinitis, Allergic; Ribosomal Proteins; Ribosomes; Risk Assessment; Risk Factors; Ritonavir; Rivers; RNA Interference; RNA-Seq; RNA, Messenger; RNA, Ribosomal, 16S; RNA, Small Interfering; Rosuvastatin Calcium; Rural Population; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salivary Ducts; Salivary Gland Neoplasms; San Francisco; SARS-CoV-2; Satiation; Satiety Response; Schools; Schools, Pharmacy; Seasons; Seawater; Selection, Genetic; Sequence Analysis, DNA; Serine-Threonine Kinase 3; Sewage; Sheep; Sheep, Domestic; Shock, Hemorrhagic; Signal Transduction; Silver; Silymarin; Single Photon Emission Computed Tomography Computed Tomography; Sirolimus; Sirtuin 1; Skin; Skin Neoplasms; Skin Physiological Phenomena; Sleep Initiation and Maintenance Disorders; Social Class; Social Participation; Social Support; Soil; Soil Microbiology; Solutions; Somatomedins; Soot; Specimen Handling; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spinal Fractures; Spirometry; Staphylococcus aureus; STAT1 Transcription Factor; STAT3 Transcription Factor; Streptomyces coelicolor; Stress, Psychological; Stroke; Stroke Volume; Structure-Activity Relationship; Students, Medical; Students, Pharmacy; Substance Abuse Treatment Centers; Sulfur Dioxide; Surface Properties; Surface-Active Agents; Surveys and Questionnaires; Survival Analysis; Survival Rate; Survivin; Sweden; Swine; Swine, Miniature; Sympathetic Nervous System; T-Lymphocytes, Regulatory; Talaromyces; Tandem Mass Spectrometry; tau Proteins; Telemedicine; Telomerase; Telomere; Telomere Homeostasis; Temperature; Terminally Ill; Th1 Cells; Thiamethoxam; Thiazoles; Thiophenes; Thioredoxin Reductase 1; Thrombosis; Thulium; Thyroid Cancer, Papillary; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Time Factors; Titanium; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Transcription Factor AP-1; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transcriptome; Transforming Growth Factor beta1; Transistors, Electronic; Translational Research, Biomedical; Transplantation Tolerance; Transplantation, Homologous; Transportation; Treatment Outcome; Tretinoin; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Tubulin Modulators; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Twins; Ultrasonic Therapy; Ultrasonography; Ultraviolet Rays; United States; Up-Regulation; Uranium; Urethra; Urinary Bladder; Urodynamics; Uromodulin; Uveitis; Vasoconstrictor Agents; Ventricular Function, Left; Vero Cells; Vesicular Transport Proteins; Viral Nonstructural Proteins; Visual Acuity; Vital Capacity; Vitamin D; Vitamin D Deficiency; Vitamin K 2; Vitamins; Volatilization; Voriconazole; Waiting Lists; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Whole Genome Sequencing; Wine; Wnt Signaling Pathway; Wound Healing; Wounds and Injuries; WW Domains; X-linked Nuclear Protein; X-Ray Diffraction; Xanthines; Xenograft Model Antitumor Assays; YAP-Signaling Proteins; Yogurt; Young Adult; Zebrafish; Zebrafish Proteins; Ziziphus | 2016 |
Metformin Lowers Body Weight But Fails to Increase Insulin Sensitivity in Chronic Heart Failure Patients without Diabetes: a Randomized, Double-Blind, Placebo-Controlled Study.
Topics: Aged; Body Composition; Body Weight; Calorimetry, Indirect; Double-Blind Method; Female; Glucagon; Glycated Hemoglobin; Heart Failure; Humans; Insulin Resistance; Male; Metformin; Middle Aged; Mitochondria; Muscle, Skeletal; Oxygen Consumption; Stroke Volume | 2021 |
Metabolic effects of short-term GLP-1 treatment in insulin resistant heart failure patients.
Topics: Blood Glucose; Calorimetry, Indirect; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Fatty Acids, Nonesterified; Glucagon; Glucagon-Like Peptide 1; Glucose Clamp Technique; Glucose Tolerance Test; Heart Failure; Humans; Insulin; Insulin Resistance; Male; Middle Aged | 2012 |
Initial experience with GLP-1 treatment on metabolic control and myocardial function in patients with type 2 diabetes mellitus and heart failure.
Topics: Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Echocardiography, Doppler; Exercise Test; Glucagon; Glucagon-Like Peptide 1; Heart; Heart Failure; Humans; Infusions, Parenteral; Injections, Subcutaneous; Insulin; Male; Myocardial Contraction; Pilot Projects; Recombinant Proteins; Time Factors | 2004 |
[Studies on the cardiac effect of glucagon in patients with chronic failure of left ventricle (author's transl)].
Topics: Adult; Chronic Disease; Cyclic AMP; Female; Glucagon; Heart; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Stimulation, Chemical | 1978 |
[Zinc protamine glucagon in refractory heart failure with arrhythmia].
Topics: Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Delayed-Action Preparations; Drug Combinations; Drug Evaluation; Female; Glucagon; Heart Failure; Humans; Injections, Intramuscular; Male; Protamines; Zinc | 1977 |
[Combined use of glucagon and strophanthin in myocardial infarct complicated by severe cardiac insufficiency].
Topics: Acute Disease; Adult; Aged; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Glucagon; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Infarction; Strophanthins; Time Factors | 1978 |
[Glucagon in the acute stage of myocardial infarct].
Topics: Adult; Aged; Clinical Trials as Topic; Female; Glucagon; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Shock, Cardiogenic | 1973 |
[Cardiological use of glucagon-zinc-protamine in diabetes].
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Diabetes Complications; Female; Glucagon; Heart Diseases; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Protamines; Shock, Cardiogenic; Zinc | 1972 |
[Glucagon. A new cardioactive drug].
Topics: Aged; Arrhythmias, Cardiac; Clinical Trials as Topic; Drug Evaluation; Female; Glucagon; Heart; Heart Failure; Heart Valve Prosthesis; Hemodynamics; Humans; Male; Middle Aged; Shock, Cardiogenic | 1974 |
Cardiovascular effects of glucagon in man.
Topics: Adolescent; Adult; Blood Glucose; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiovascular System; Digitalis Glycosides; Dye Dilution Technique; Electrocardiography; Female; Glucagon; Heart; Heart Diseases; Heart Failure; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Middle Aged; Potassium; Vascular Resistance | 1968 |
Treatment of congestive heart failure with glucagon.
Topics: Adult; Aged; Cardiac Catheterization; Clinical Trials as Topic; Digitalis Glycosides; Diuretics; Glucagon; Heart Failure; Humans; Male; Middle Aged; Nausea; Vomiting | 1970 |
116 other study(ies) available for glucagon and Cardiac Failure
| Article | Year |
|---|---|
Glucose Homeostasis, Pancreatic Endocrine Function, and Outcomes in Advanced Heart Failure.
Topics: Aged; Biomarkers; Blood Glucose; Cachexia; Case-Control Studies; Female; Glucagon; Glucose Tolerance Test; Heart Failure; Homeostasis; Humans; Insulin; Islets of Langerhans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Risk Factors; Severity of Illness Index; Time Factors; Ventricular Dysfunction, Right; Ventricular Function, Right | 2017 |
Glucagon secretion determined by the RIA method is lower in patients with low left ventricular ejection fraction: The new glass study.
Topics: Aged; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Heart Failure; Humans; Incidence; Japan; Male; Prospective Studies; Radioimmunoassay; Ventricular Dysfunction, Left | 2018 |
Does glucagon have a positive inotropic effect in the human heart?
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Calcium Signaling; Cardiotonic Agents; Glucagon; Heart; Heart Failure; Heart Rate; Humans; Myocardial Contraction; Treatment Outcome; Ventricular Function, Left | 2018 |
The possible role of insulin and glucagon in patients with heart failure and Type 2 diabetes.
Topics: Blood Glucose; Cardiology; Diabetes Mellitus, Type 2; Glucagon; Heart Failure; Humans; Insulin; Translational Research, Biomedical | 2020 |
Response to 'The possible role of insulin and glucagon in patients with heart failure and Type 2 diabetes'.
Topics: Blood Glucose; Cardiology; Diabetes Mellitus, Type 2; Glucagon; Heart Failure; Humans; Insulin; Translational Research, Biomedical | 2020 |
Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy.
Topics: Animals; Blood Glucose; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Consciousness; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Energy Metabolism; Fatty Acids; Female; Glucagon; Glucagon-Like Peptide 1; Glucose; Glucose Clamp Technique; Heart Failure; Hemodynamics; Hyperinsulinism; Infusions, Intravenous; Insulin Resistance; Male; Myocardium; Oxygen Consumption; Peptide Fragments; Protein Precursors; Recombinant Proteins; Ventricular Dysfunction, Left | 2004 |
Cardiac metabolism as a target for the treatment of heart failure.
Topics: Acetanilides; Animals; Dogs; Energy Metabolism; Epoxy Compounds; Fatty Acids; Forecasting; Glucagon; Glucagon-Like Peptide 1; Glucose; Heart Failure; Humans; Insulin Resistance; Myocardium; Peptide Fragments; Piperazines; Protein Precursors; Ranolazine; Recombinant Proteins | 2004 |
Respiratory gas tensions of thoracic duct lymph: an index of gas exchange in splanchnic tissues.
Topics: Ammonium Chloride; Animals; Bicarbonates; Blood Flow Velocity; Blood Gas Analysis; Carbon Dioxide; Cyanides; Dogs; Glucagon; Heart Arrest; Heart Failure; Humans; Hydrogen-Ion Concentration; Liver Diseases; Lymph; Oxygen; Oxygen Consumption; Shock, Hemorrhagic; Thoracic Duct; Vasopressins | 1967 |
Drugs and the heart. V. Digitalis and sympathomimetic stimulants.
Topics: Arrhythmias, Cardiac; Cell Membrane; Coronary Disease; Digitalis Glycosides; Glucagon; Heart Failure; Humans; Kinetics; Myocardial Contraction; Myocardium; Potassium; Receptors, Drug; Stimulation, Chemical; Sympathomimetics | 1980 |
[Success and prospects in the therapy of heart failure in children].
Topics: Adrenergic beta-Antagonists; Anticoagulants; Cardiac Glycosides; Child; Diuretics; Drug Evaluation; Glucagon; Glucocorticoids; Heart Failure; Hemodynamics; Humans; Intestinal Absorption; Kinetics; Protein Binding; Vasodilator Agents | 1981 |
Vasoactive intestinal peptide in shock and heart failure.
Topics: Adult; Aged; Female; Gastrointestinal Hormones; Glucagon; Heart Diseases; Heart Failure; Humans; Male; Middle Aged; Pancreatic Polypeptide; Shock; Vasoactive Intestinal Peptide | 1983 |
Inotropic drugs for treatment of the failing heart.
Topics: Aminophylline; Aminopyridines; Amrinone; Cardiotonic Agents; Catecholamines; Digitalis Glycosides; Glucagon; Heart Failure; Hemodynamics; Humans; Milrinone; Myocardial Contraction; Pyridones; Receptors, Adrenergic, beta; Theophylline | 1984 |
Sulfonamide-induced hypoglycemia in chronic renal failure.
Topics: Aged; Alanine; Female; Glucagon; Glucose; Glucose Tolerance Test; Growth Hormone; Heart Failure; Humans; Hydrocortisone; Hypoglycemia; Insulin; Kidney Failure, Chronic; Sulfonamides; Time Factors; Urinary Tract Infections | 1983 |
[Immunoreactive glucagon level in the blood plasma and carbohydrate metabolic disorders in acute myocardial infarct].
Topics: Adult; Aged; Blood Glucose; Carbohydrates; Glucagon; Glucose Tolerance Test; Heart Failure; Humans; Middle Aged; Myocardial Infarction; Time Factors | 1982 |
[Nonglycoside drugs in the treatment of congestive circulatory insufficiency].
Topics: Adenosine Triphosphate; Amino Acids; Anabolic Agents; Cardiac Glycosides; Glucagon; Heart Failure; Humans; Inosine; Myocardial Contraction; Water-Electrolyte Balance | 1982 |
[Hemodynamic effects of glucagon, isoprenaline and dopamine in patients with congestive circulatory insufficiency].
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Dopamine; Female; Glucagon; Heart Failure; Heart Rate; Humans; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Stroke Volume | 1982 |
Use of glucagon to treat neonatal low-output congestive heart failure after maternal labetalol therapy.
Topics: Adult; Eclampsia; Female; Glucagon; Heart Failure; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Labetalol; Maternal Welfare; Mothers; Pregnancy; Treatment Outcome | 1995 |
Metabolic responses to graded exercise in chronic heart failure.
Topics: Aged; Blood Glucose; Chronic Disease; Epinephrine; Exercise Test; Fatty Acids, Nonesterified; Female; Glucagon; Glycerol; Heart Failure; Humans; Insulin; Male; Middle Aged; Norepinephrine | 1993 |
Volume overload heart failure: length-tension curves, and response to beta-agonists, Ca2+, and glucagon.
Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Calcium; Dogs; Dose-Response Relationship, Drug; Glucagon; Heart Failure; Heart Rate; Isoproterenol; Myocardial Contraction; Norepinephrine; Stimulation, Chemical | 1978 |
[Action of glucagon on the systolic time interval and on cyclic-AMP plasma concentration in patients with chronic myocardial insufficiency].
Topics: Blood Pressure; Chronic Disease; Cyclic AMP; Glucagon; Heart Failure; Humans; Time Factors | 1977 |
[Cardiovascular complications during treatment by verapamil. A propos of 6 cases].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Cardiomegaly; Female; Glucagon; Heart Failure; Humans; Isoproterenol; Male; Middle Aged; Pulmonary Edema; Shock, Cardiogenic; Verapamil | 1975 |
[Haemodynamic effects of depot zinc protamine glucagon in heart failure (author's transl)].
Topics: Aged; Blood Pressure; Delayed-Action Preparations; Female; Glucagon; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Pulmonary Circulation; Stroke Volume; Vascular Resistance | 1979 |
Cardiac consequences and treatment of disopyramide intoxication: experimental evaluation in dogs.
Topics: Animals; Arrhythmias, Cardiac; Disopyramide; Dogs; Dopamine; Electrocardiography; Glucagon; Heart Arrest; Heart Failure; Hemodynamics; Isoproterenol; Pyridines | 1979 |
[Acute cardiac insufficiency].
Topics: Acid-Base Equilibrium; Anti-Bacterial Agents; Child; Diagnosis, Differential; Digitalis Glycosides; Diuretics; Electrolytes; Glucagon; Heart Failure; Hemodynamics; Humans; Hyperbaric Oxygenation; Oxygen Inhalation Therapy | 1978 |
[Treatment of refractory cardiac insufficiency with infusion of glucagon, insulin, glucose and potassium].
Topics: Aged; Arrhythmias, Cardiac; Coronary Disease; Drug Combinations; Drug Evaluation; Female; Glucagon; Glucose; Heart Block; Heart Failure; Humans; Infusions, Parenteral; Insulin; Potassium | 1978 |
[Use of glucagon in cardiac glycoside poisoning in patients with congestive circulatory insufficiency].
Topics: Adult; Aged; Cardiac Glycosides; Female; Glucagon; Heart Failure; Humans; Male; Middle Aged | 1977 |
[Glucagon as a cardiac drug].
Topics: Adolescent; Drug Evaluation; Female; Glucagon; Heart Failure; Humans | 1976 |
[Polycardiographic evaluation of left ventricular contraction following glucagon administration to patients with chronic circulatory failure].
Topics: Adolescent; Adult; Chronic Disease; Female; Glucagon; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction | 1976 |
[Use of glucagon in the treatment of severe contractile insufficiency of the myocardium].
Topics: Adult; Aged; Drug Evaluation; Female; Glucagon; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Shock, Cardiogenic | 1976 |
[Behavior of various endocrine and metabolic parameters in heart patients treated with glucagon].
Topics: Aged; Fatty Acids, Nonesterified; Female; Glucagon; Growth Hormone; Heart Failure; Humans; Insulin; Male; Middle Aged | 1976 |
[Cardiological emergencies in old age].
Topics: Aging; Anticoagulants; Arrhythmias, Cardiac; Cardiac Glycosides; Coronary Disease; Diuretics; Electric Stimulation Therapy; Glomerular Filtration Rate; Glucagon; Heart Diseases; Heart Failure; Humans; Posture; Pulmonary Edema; Pulmonary Embolism | 1975 |
[Glucagon in circulatory failure of coronary origin refractory to digitalis treatment].
Topics: Digitalis Glycosides; Glucagon; Heart Failure; Heart Ventricles; Humans; Injections, Intravenous; Male; Middle Aged | 1975 |
[Use of glucagon for the treatment of acute cardiac insufficiency during open-heart surgery].
Topics: Acute Disease; Cardiac Surgical Procedures; Child; Child, Preschool; Glucagon; Heart; Heart Arrest; Heart Defects, Congenital; Heart Diseases; Heart Failure; Hemodynamics; Humans; Male | 1975 |
[Effect of glucagon on the left ventricular function in patients with congestive heart failure (author's transl)].
Topics: Adolescent; Adult; Female; Glucagon; Heart; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged | 1975 |
[Therapeutic action of glucagon on pathological states of the myocardium, especially on specific conduction tissue disorders].
Topics: Adult; Aged; Female; Glucagon; Heart Block; Heart Conduction System; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction | 1975 |
Letter: Correction of heart failure with treatment of hyperglycemia.
Topics: Animals; Catecholamines; Dogs; Glucagon; Heart Failure; Humans; Hyperglycemia; Insulin; Myocardial Contraction; Rabbits | 1976 |
[Use of glucagon in the therapy of cardiac insufficiency].
Topics: Adult; Aged; Coronary Disease; Female; Glucagon; Heart Failure; Heart Valve Diseases; Humans; Male; Middle Aged; Pulmonary Edema; Pulmonary Heart Disease | 1976 |
Glucagon in diphtheritic myocarditis.
Topics: Child; Child, Preschool; Diphtheria; Glucagon; Heart Failure; Humans; Injections, Intravenous; Myocarditis | 1971 |
[Glucagon in heart failure].
Topics: Adrenergic beta-Antagonists; Cardiac Output; Glucagon; Heart; Heart Failure; Heart Rate; Humans; Poisoning; Shock, Cardiogenic | 1974 |
Glucagon therapy in heart-failure.
Topics: Adult; Aged; Female; Glucagon; Heart Failure; Humans; Injections, Intravenous; Male | 1969 |
Glucagon therapy in heart-failure.
Topics: Animals; Cyclic AMP; Dogs; Glucagon; Heart Failure; Humans; Propranolol | 1969 |
Glucagon therapy in heart-failure.
Topics: Glucagon; Heart Block; Heart Failure; Hemodynamics; Humans | 1969 |
Glucagon therapy in heart-failure.
Topics: Glucagon; Heart Failure; Humans; Propranolol | 1969 |
Glucagon in resistant heart-failure and cardiogenic shock.
Topics: Adult; Bundle-Branch Block; Cardiac Glycosides; Cardiac Output; Cardiomegaly; Diuretics; Electrolytes; Glucagon; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Shock; Urea | 1970 |
Glucagon in cardiac failure.
Topics: Animals; Glucagon; Heart; Heart Failure; Humans; Norepinephrine | 1970 |
The influence of glucagon on myocardial mechanics of papillary muscles obtained from patients with chronic congestive heart failure.
Topics: Chronic Disease; Glucagon; Heart; Heart Failure; Humans; In Vitro Techniques; Muscle Contraction; Papillary Muscles | 1971 |
Relationships among hypertrophy, hypertension, and coronary arterial patterns, and pharmacological responses in cardiomyopathies.
Topics: Cardiomegaly; Cardiomyopathy, Hypertrophic; Coronary Disease; Coronary Vessels; Glucagon; Heart Failure; Humans; Hypertension; Phentolamine; Practolol | 1973 |
Glucagon.
Topics: Adenoma, Islet Cell; Animals; Arrhythmias, Cardiac; Carbohydrate Metabolism; Dogs; Glucagon; Glycogen Storage Disease; Heart; Heart Failure; Humans; Hypoglycemia; Hypopituitarism; Injections, Intramuscular; Injections, Subcutaneous; Pheochromocytoma; Shock, Cardiogenic | 1971 |
Effects of glucagon on adenyl cyclase activity in the left and right ventricles and liver in experimentally-produced isolated right ventricular failure.
Topics: Adenosine Triphosphate; Adenylyl Cyclases; Animals; Cardiac Catheterization; Cats; Culture Techniques; Cyclic AMP; Enzyme Induction; Epinephrine; Glucagon; Heart Failure; Heart Ventricles; Ligation; Liver; Myocardium; Norepinephrine; Pulmonary Artery; Stimulation, Chemical; Tritium | 1970 |
Glucagon in heart failure and in cardiogenic shock. Experience in 50 patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Body Weight; Digitalis Glycosides; Female; Furosemide; Glucagon; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Nausea; Postoperative Complications; Prochlorperazine; Shock, Cardiogenic; Spironolactone | 1972 |
[Use of glucagon in small doses and reinfusion of desalted and concentrated ascitic fluid in the therapy of refractory cardiac decompensation].
Topics: Ascitic Fluid; Glucagon; Heart Failure; Humans; Methods; Sodium | 1974 |
Aortic velocity and acceleration measurements in the assessment of coronary heart disease.
Topics: Acute Disease; Angina Pectoris; Aorta; Blood Flow Velocity; Blood Pressure Determination; Cardiac Catheterization; Cardiac Output; Coronary Artery Bypass; Coronary Disease; Electrocardiography; Female; Glucagon; Heart Conduction System; Heart Failure; Heart Ventricles; Humans; Male; Mitral Valve Insufficiency; Myocardial Infarction; Ouabain; Prognosis; Regional Blood Flow | 1974 |
Right to left shunt in patients with acute myocardial infarction. A proposed mechanism.
Topics: Blood Pressure; Body Surface Area; Carbon Dioxide; Cardiac Catheterization; Cardiac Output; Collateral Circulation; Digoxin; Electrocardiography; Glucagon; Heart Failure; Humans; Isoproterenol; Lung; Myocardial Infarction; Norepinephrine; Oxygen; Positive-Pressure Respiration; Pulmonary Artery; Pulmonary Circulation; Shock, Cardiogenic | 1972 |
[Drug therapy of hemodynamic complications in acute myocardial infarct].
Topics: Aged; Analgesia; Anti-Arrhythmia Agents; Blood Volume; Bradycardia; Cardiovascular Diseases; Diazepam; Digoxin; Diuretics; Dopamine; Glucagon; Heart Failure; Humans; Hypertension; Hypotension; Male; Myocardial Infarction; Norepinephrine; Phentolamine; Plasma Substitutes; Potassium; Tachycardia | 1972 |
[Treatment of cardiac failure].
Topics: Acid-Base Equilibrium; Adolescent; Adult; Child; Child, Preschool; Digitalis Glycosides; Diuretics; Enteral Nutrition; Glucagon; Heart Failure; Humans; Infant; Infant, Newborn; Metaproterenol; Oxygen Inhalation Therapy; Respiration, Artificial; Respiratory Insufficiency; Rest | 1972 |
[Glucagon in the treatment of chronic congestive heart failure].
Topics: Adult; Chronic Disease; Electrocardiography; Female; Glucagon; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Water-Electrolyte Balance | 1972 |
[Differential diagnosis and therapy of digitalis-refractory heart failure].
Topics: Adrenal Cortex Hormones; Adult; Diagnosis, Differential; Digitalis Glycosides; Diuretics; Female; Fibrinolytic Agents; Glucagon; Heart Failure; Humans; Male; Middle Aged; Pulmonary Heart Disease | 1972 |
[Glucagon in the therapy of low cardiac output syndromes].
Topics: Glucagon; Heart Failure; Humans; Injections, Intravenous; Shock, Cardiogenic | 1972 |
[Zinc-protamine-glucagon in the therapy of heart failure].
Topics: Arrhythmias, Cardiac; Blood Glucose; Blood Pressure; Diuresis; Fatty Acids, Nonesterified; Glucagon; Heart Failure; Humans; Injections, Subcutaneous; Protamines; Zinc | 1972 |
[Heart therapy using zinc protamine glucagon].
Topics: Drug Combinations; Glucagon; Heart Failure; Humans; Protamines; Zinc | 1972 |
[General treatment of heart failure].
Topics: Cardiac Glycosides; Diet Therapy; Diuretics; Glucagon; Heart Failure; Humans; Purines; Rest | 1972 |
[Use of glucagon in heart decompensation: personal case reports].
Topics: Adult; Aged; Female; Glucagon; Heart Failure; Humans; Male; Middle Aged | 1972 |
Recent advances in therapy for refractory congestive heart failure.
Topics: Adrenal Cortex Hormones; Aminophylline; Cardiac Catheterization; Cardiomyopathies; Dextrothyroxine; Digitalis Glycosides; Diuretics; Dopamine; Ethacrynic Acid; Furosemide; Glucagon; Heart; Heart Diseases; Heart Failure; Humans; Isoproterenol; Mannitol; Mineralocorticoid Receptor Antagonists; Pacemaker, Artificial | 1973 |
[Toxi-infectious shock].
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Blood Transfusion; Chlorpromazine; Digitalis Glycosides; Glucagon; Heart Failure; Humans; Infections; Isoproterenol; Kidney Diseases; Lung Diseases; Metabolic Diseases; Oxygen Inhalation Therapy; Phenoxybenzamine; Plasma Substitutes; Sepsis; Shock, Septic; Vasodilator Agents | 1973 |
[Glucagon in the therapy of cardiac insufficiency. Clinical study of 50 treated cases].
Topics: Arrhythmias, Cardiac; Electrocardiography; Female; Glucagon; Heart Conduction System; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction | 1973 |
Glucagon: its enhancement of cardiac performance in the cat with chronic heart failure.
Topics: Animals; Blood Pressure; Cardiac Output; Cats; Chronic Disease; Dose-Response Relationship, Drug; Glucagon; Heart; Heart Failure; Heart Rate; Heart Ventricles; Organ Size; Pulmonary Artery; Stimulation, Chemical | 1973 |
Chronic congestive heart failure treated with long-term infusion of glucagon.
Topics: Aged; Bicarbonates; Blood; Blood Pressure; Body Weight; Chlorides; Depression, Chemical; Dyspnea; Female; Glucagon; Heart Failure; Humans; Hydrogen-Ion Concentration; Infusions, Parenteral; Male; Middle Aged; Nausea; Photometry; Potassium; Pulse; Sodium; Time Factors | 1973 |
[The cardiotonic effect of glucagon. Clinical study and therapeutic indications].
Topics: Arrhythmias, Cardiac; Digitalis Glycosides; Glucagon; Heart Diseases; Heart Failure; Humans; Shock, Cardiogenic | 1973 |
[Method for hemodynamic and metabolic evaluation of patients needing intensive therapy. In reference to the experiences of Dr. Siegel and coworkers].
Topics: Glucagon; Heart Failure; Hemodynamics; Humans; Intensive Care Units; Isoproterenol; Liver Cirrhosis; Metabolism; Myocardial Infarction; Shock | 1973 |
[Therapy of heart failure using zinc-protamine-glucagon].
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Body Weight; Electrocardiography; Fatty Acids, Nonesterified; Female; Glucagon; Heart Failure; Humans; Injections, Subcutaneous; Male; Middle Aged; Protamines; Zinc | 1973 |
[Glucagon as a life-saving drug].
Topics: Adult; Aged; Coma; Coronary Disease; Female; Glucagon; Heart Arrest; Heart Failure; Humans; Male; Middle Aged; Pulmonary Edema; Pulmonary Heart Disease | 1973 |
[Glucagon and renal function].
Topics: Adult; Aged; Calcium; Chlorides; Creatinine; Diuresis; Glucagon; Heart Failure; Humans; Kidney; Kidney Function Tests; Middle Aged; Natriuresis; Potassium; Urea; Water-Electrolyte Balance | 1973 |
[Use of glucagon in heart decompensation].
Topics: Adult; Aged; Drug Evaluation; Female; Glucagon; Heart Failure; Humans; Male; Middle Aged | 1973 |
[Experience with using glucagon in acute myocardial infarct].
Topics: 11-Hydroxycorticosteroids; Acid-Base Equilibrium; Acute Disease; Adult; Aged; Arrhythmias, Cardiac; Blood Gas Analysis; Catecholamines; Female; Glucagon; Heart Block; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Kinins; Male; Middle Aged; Myocardial Infarction; Plethysmography, Impedance; Shock, Cardiogenic; Transcortin | 1974 |
The effect of prolonged glucagon infusions on the urinary excretion of catecholamines and 4-hydroxy-3-methoxymandelic acid and on adrenal medullary tissue levels of catecholamines in patients with severe cardiac disease.
Topics: Adrenal Medulla; Adult; Aged; Chromatography, Thin Layer; Dopamine; Epinephrine; Female; Glucagon; Heart Failure; Humans; Infusions, Parenteral; Male; Mandelic Acids; Middle Aged; Norepinephrine; Prochlorperazine; Time Factors | 1974 |
Hemodynamic evaluation of glucagon in symptomatic heart disease.
Topics: Blood Pressure; Cardiac Catheterization; Cardiac Output; Coronary Disease; Dye Dilution Technique; Glucagon; Heart Diseases; Heart Failure; Heart Rate; Heart Valve Diseases; Humans; Isoproterenol; Stimulation, Chemical; Vascular Resistance | 1971 |
[Hemodynamic action of glucagon during the acute phase of myocardial infarct in man].
Topics: Acute Disease; Adult; Aged; Cardiac Catheterization; Cardiovascular System; Female; Glucagon; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction | 1971 |
Glucagon. A perspective.
Topics: Adenylyl Cyclases; Cardiac Output; Glucagon; Heart Diseases; Heart Failure; Humans; Myocardium; Oxygen Consumption; Papillary Muscles; Shock, Cardiogenic | 1972 |
[Cardiovascular effects of glucagon].
Topics: Animals; Arrhythmias, Cardiac; Cardiovascular System; Glucagon; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Shock, Cardiogenic | 1972 |
Medical tretment and mortality in cardiogenic shock. Metaraminol compared with combined phentolamine and norepinephrine. Glucagon therapy.
Topics: Adult; Aged; Central Venous Pressure; Digitalis Glycosides; Drug Combinations; Female; Glucagon; Heart Failure; Humans; Male; Metaraminol; Middle Aged; Myocardial Infarction; Norepinephrine; Phentolamine; Prognosis; Radiography, Thoracic; Shock, Cardiogenic | 1972 |
Effects of long-term infusion of glucagon on carbohydrate metabolism, insulin and growth hormone secretion in patients with congestive heart failure.
Topics: Aged; Antigens; Blood Glucose; Dietary Carbohydrates; Fatty Acids, Nonesterified; Female; Glucagon; Glucose Tolerance Test; Growth Hormone; Heart Failure; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Insulin; Insulin Secretion; Male; Middle Aged; Phosphorus; Potassium | 1972 |
[Low doses of glucagon in the treatment of congestive heart failure].
Topics: Adolescent; Female; Glucagon; Heart Failure; Humans; Male; Middle Aged; Tachycardia | 1972 |
Effects of glucagon on atrio-ventricular conduction in man.
Topics: Adult; Aged; Electrocardiography; Female; Glucagon; Heart Block; Heart Conduction System; Heart Failure; Heart Rate; Humans; Male; Metaproterenol; Middle Aged; Pulmonary Heart Disease; Time Factors | 1972 |
[Metabolic effect of glucagon in chronic cardiac insufficiency].
Topics: Blood Glucose; Fatty Acids, Nonesterified; Glucagon; Glucose; Heart Failure; Humans; Insulin; Metabolic Clearance Rate | 1972 |
Acute myocardial infarction in man. Comparative hemodynamic effects of norepinephrine and glucagon.
Topics: Aged; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiac Volume; Female; Glucagon; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Norepinephrine; Oxygen Consumption; Vascular Resistance | 1971 |
Effects of chronic heart failure on the capacity of glucagon to enhance contractility and adenyl cyclase activity of human papillary muscles.
Topics: Adenylyl Cyclases; Adolescent; Adult; Binding Sites; Cardiac Catheterization; Female; Glucagon; Heart; Heart Failure; Heart Rate; Humans; In Vitro Techniques; Male; Middle Aged; Myocardium; Norepinephrine; Papillary Muscles | 1971 |
[Cardiac action of glucagon in patients with heart diseases].
Topics: Adult; Blood Pressure; Glucagon; Heart; Heart Failure; Heart Rate; Humans; Injections, Intravenous; Isoproterenol; Middle Aged; Time Factors | 1971 |
[Glucagon in cardiogenic shock].
Topics: Aged; Blood Pressure; Glucagon; Heart Failure; Heart Rate; Humans; Middle Aged; Myocardial Infarction; Shock, Cardiogenic; Vascular Resistance | 1971 |
[Glucagon in congestive heart failure with digitalis toxicosis].
Topics: Adult; Aged; Digitalis Glycosides; Female; Glucagon; Heart Diseases; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction | 1971 |
[Metabolic effects of glucagon in subjects with a healthy heart and subjects with heart disease].
Topics: Glucagon; Heart Failure; Humans; Insulin; Insulin Secretion; Lactates; Myocardium; Pyruvates; Shock, Cardiogenic | 1971 |
[Effect of glucagon on the insufficient myocardium].
Topics: Blood Circulation Time; Blood Pressure Determination; Glucagon; Heart Failure; Heart Rate; Humans | 1971 |
[Complicated cardiac insufficiency and recent therapeutic possibilities: case report].
Topics: Ajmaline; Arrhythmias, Cardiac; Digoxin; Electric Countershock; Female; Glucagon; Heart Failure; Humans; Lanatosides; Middle Aged; Mitral Valve Insufficiency; Phenytoin; Phytotherapy; Plants, Medicinal; Pulmonary Edema; Quinidine; Rauwolfia; Water-Electrolyte Balance | 1971 |
[Experimental studies on functional insufficiency of the superior mesenteric artery].
Topics: Animals; Cardiac Output; Dogs; Enterocolitis, Pseudomembranous; Glucagon; Heart Failure; Intestinal Pseudo-Obstruction; Mesenteric Arteries; Mesenteric Vascular Occlusion; Phentolamine; Postoperative Complications; Regional Blood Flow | 1971 |
Efficacy of glucagon therapy in heart failure.
Topics: Aged; Glucagon; Heart Failure; Humans; Male | 1970 |
Glucagon as a cardiotonic agent.
Topics: Acute Disease; Glucagon; Heart Failure | 1970 |
[Cardiotonic effect of glucagon].
Topics: Arrhythmias, Cardiac; Glucagon; Heart Diseases; Heart Failure; Pulmonary Embolism; Respiratory Insufficiency; Shock, Cardiogenic | 1970 |
Effects of glucagon on myocardial contractility and hemodynamics in acute experimental myocardial infarction. Basis for its possible use in cardiogenic shock.
Topics: Animals; Blood Pressure; Cardiac Output; Dogs; Glucagon; Heart; Heart Failure; Heart Rate; Hemodynamics; Myocardial Infarction; Shock; Vascular Resistance | 1969 |
The effect of glucagon on the coronary circulation in man.
Topics: Adult; Aged; Arteries; Blood Circulation; Blood Flow Velocity; Blood Pressure; Coronary Disease; Coronary Vessels; Female; Glucagon; Heart; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Infusions, Parenteral; Isoproterenol; Male; Middle Aged; Myocardium; Norepinephrine; Oxygen Consumption; Radioisotope Dilution Technique; Radioisotopes; Regional Blood Flow; Rubidium; Stimulation, Chemical; Vascular Resistance | 1969 |
The hemodynamic and metabolic effects of glucagon in patients with chronic valvular heart disease.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Cardiac Catheterization; Cardiac Output; Chronic Disease; Female; Glucagon; Heart Failure; Heart Rate; Heart Valve Diseases; Hemodynamics; Humans; Male; Middle Aged; Rheumatic Heart Disease | 1970 |
Clinical evaluation of glucagon by continuous infusion in the treatment of low cardiac output states.
Topics: Adult; Aged; Blood Glucose; Blood Pressure; Cardiac Output; Diuresis; Drug Stability; Female; Glucagon; Heart Failure; Heart Rate; Humans; Hypoglycemia; Injections, Intravenous; Male; Middle Aged; Shock; Time Factors; Water-Electrolyte Balance | 1970 |
Treatment of cardiac failure with glucagon.
Topics: Animals; Dogs; Glucagon; Heart Failure; Humans | 1970 |
Haemodynamic effects of glucagon.
Topics: Acute Disease; Adult; Aged; Blood Glucose; Blood Pressure; Cardiac Output; Cardiac Surgical Procedures; Female; Glucagon; Heart Failure; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Liver Glycogen; Male; Middle Aged; Mitral Valve Stenosis; Myocardial Infarction; Pulmonary Artery; Rheumatic Heart Disease; Vascular Resistance | 1970 |
Effects of experimental heart failure on the capacity of glucagon to augment myocardial contractility and activate adenyl cyclase.
Topics: Adenylyl Cyclases; Animals; Cardiac Catheterization; Cats; Enzymes; Glucagon; Heart; Heart Failure; Muscle Contraction; Myocardium; Norepinephrine; Papillary Muscles | 1970 |
Glucagon and the failing heart.
Topics: Adenylyl Cyclases; Animals; Cats; Dogs; Glucagon; Heart Failure; Humans; Thyroxine | 1970 |
[Hemodynamic changes in acute myocardial inferct].
Topics: Arrhythmias, Cardiac; Blood Pressure; Glucagon; Heart Failure; Heart Rate; Hemodynamics; Humans; Lanatosides; Myocardial Infarction; Resorcinols | 1970 |
[Glucagon and cardiac decompensation].
Topics: Digitalis Glycosides; Drug Synergism; Glucagon; Heart Failure; Humans | 1970 |
[Cardiotonic effects of glucagon].
Topics: Acute Disease; Adolescent; Adult; Aged; Animals; Blood Pressure; Cardiac Output; Dyspnea; Female; Glucagon; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Nausea; Pulse; Shock, Cardiogenic; Time Factors; Venous Pressure | 1970 |
Diminished responsiveness of the failing human myocardium to glucagon.
Topics: Animals; Cats; Dogs; Electric Stimulation; Glucagon; Heart; Heart Failure; Heart Valve Diseases; Humans; In Vitro Techniques; Isoproterenol; Muscle Contraction; Papillary Muscles | 1970 |
Phenol with glucagon in cardiotherapy.
Topics: Glucagon; Heart Failure; Humans; Injections, Intravenous; Phenols; Solutions | 1971 |
The effects of glucagon on sodium, potassium, and urine excretion in patients in congestive heart failure.
Topics: Creatinine; Diuresis; Dopamine; Electrocardiography; Glucagon; Heart Failure; Humans; Injections, Intravenous; Natriuresis; Potassium; Sodium | 1971 |
Glucagon in congestive heart failure.
Topics: Aged; Blood Glucose; Blood Pressure; Blood Urea Nitrogen; Calcium; Carbon Dioxide; Cardiac Output; Glucagon; Heart Failure; Heart Rate; Humans; Hydrogen-Ion Concentration; Ischemia; Lung Diseases, Obstructive; Middle Aged; Nausea; Oxygen; Potassium; Pulmonary Heart Disease; Urine | 1971 |
Glucagon in heart block.
Topics: Aged; Blood Pressure; Female; Glucagon; Heart Block; Heart Failure; Heart Rate; Humans; Natriuresis; Pacemaker, Artificial | 1971 |
The role of glucagon in cardiac therapy.
Topics: Arrhythmias, Cardiac; Glucagon; Heart; Heart Block; Heart Conduction System; Heart Diseases; Heart Failure; Heart Rate; Hemodynamics; Humans | 1971 |
Haemodynamic effects of glucagon during acute myocardial infarction with left ventricular failure in man.
Topics: Acute Disease; Aged; Blood Glucose; Blood Pressure; Cardiac Output; Cardiac Volume; Female; Glucagon; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Nausea; Potassium; Pulmonary Circulation; Vascular Resistance; Vomiting | 1971 |
Glucagon in refractory heart failure.
Topics: Aged; Glucagon; Heart Failure; Humans; Male; Pulmonary Edema | 1971 |
Glucagon. Its enhancement of cardiac performance in the cat and dog and persistence of its inotropic action despite beta-receptor blockade with propranolol.
Topics: Animals; Blood Pressure; Catecholamines; Cats; Dogs; Glucagon; Heart; Heart Atria; Heart Failure; Heart Rate; Hindlimb; In Vitro Techniques; Muscle Contraction; Papillary Muscles; Propranolol; Receptors, Drug; Reserpine; Vascular Resistance | 1968 |